A new “life-changing” treatment has been rolled out to sickle cell patients through the NHS which will benefit thousands of people living with the illness.
The new treatment, crizanlizumab, will reduce chronic pain and trips to A&E while improving patients’ quality of life, healthcare providers have said.
